CircuLite Awarded Grant from Cardiovascular Medical Research and Education Fund to Develop Right-Heart Circulatory Support System for Patients with Pulmonary Arterial Hypertension (PAH)
1/4/2012 7:40:01 AM
SADDLE BROOK, N.J.--(BUSINESS WIRE)--CircuLite®, Inc. today announced that it has received a grant from the Cardiovascular Medical Research and Education Fund, Inc. (CMREF) to fund the development of a right-heart circulatory support system based upon CircuLite’s Synergy® Micro-pump for the treatment of right heart failure due to pulmonary arterial hypertension (PAH) and other causes. The Synergy system includes a micro-blood pump the size of a AA battery that can be implanted superficially in a “pacemaker-like” pocket. Synergy is the first and smallest surgically implanted device designed for partial circulatory support (up to 4.25L/min) in patients with heart failure. CircuLite is currently conducting a clinical trial with Synergy in patients with Class IIIB/early Class IV heart failure at multiple centers in Europe, aimed at achieving CE Mark.
comments powered by